Priscila Preciado

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

All-cause mortality in relation to changes in relative blood volume during hemodialysis

Priscila Preciado, Hanjie Zhang, Stephan Thijssen et al. · Nephrology Dialysis Transplantation · 2018 · 40 citations · Full text

Association between intradialytic central venous oxygen saturation and ultrafiltration volume in chronic hemodialysis patients

Hanjie Zhang, Lili Chan, Anna Meyring-Wösten et al. · Nephrology Dialysis Transplantation · 2017 · 31 citations · Full text

Relationships between Neighborhood Walkability and Objectively Measured Physical Activity Levels in Hemodialysis Patients

Maggie Han, Xiaoling Ye, Priscila Preciado et al. · Blood Purification · 2018 · 27 citations

Dialysis Access as an Area of Improvement in Elderly Incident Hemodialysis Patients: Results from a Cohort Study from the International Monitoring Dialysis Outcomes Initiative

Jochen G. Raimann, Cláudia Barth, Len A. Usvyat et al. · American Journal of Nephrology · 2017 · 20 citations · Full text